NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- On August 3, Zami Aberman,
Chief Executive Officer for Pluristem Life Systems, Inc. (OTC Bulletin
Board: PLRS -
News) updated the
investment community in an exclusive interview with
www.wallst.net . Topics covered in
the interview include an overview of the Company and the markets it
serves, recent press releases, current capitalization, upcoming
strategic and financial milestones.
To hear the interview in its entirety, visit www.wallst.net , and click
on "Interviews." Interviews require free registration, and can be
accessed either by locating the respective company's ticker symbol under
the appropriate exchange on the left-hand column of the "Interviews"
section of the site, or by entering the respective company's ticker
symbol in the Search Archive window.
About Pluristem:
Pluristem Life Systems, Inc. is a cell therapy company dedicated to the
commercialization of stem cell therapy products for the treatment of
severe blood disorders. Pluristem is discovering and developing
cell-based therapeutics utilizing adult stem cells expanded in a
proprietary bioreactor that mimics different naturally occurring
physiological environments. Pluristem expects its first products to be
cell grafts that will provide an efficient and superior alternative to
the standard procedure of bone marrow transplantation to treat blood
cancer and other blood disorders.
About WallSt.net:
www.wallst.net is owned and
operated by WallStreet Direct, Inc., a wholly owned subsidiary of
Financial Media Group, Inc. The website is a leading provider of
financial news, media, tools and community-driven applications for
investors. www.wallst.net offers visitors free membership to its
in-depth executive interviews, exclusive editorial content, breaking
news, and several proprietary applications. In addition to its website,
WallStreet Direct organizes investor conferences, publishes a newspaper,
and provides multimedia advertising solutions to small and mid-sized
publicly traded companies. We are expecting to receive one hundred
seventy five dollars from a third party on behalf of Pluristem Life
Systems for the dissemination of this press release. For a complete list
of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp
.
(Logo:
http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO ) |
